BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35029083)

  • 1. Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic Correlation.
    Park JH; Yoon YS; Lee S; Kim HY; Han HS; Lee JS; Chang W; Kim H; Na HY; Han S; Lee KH
    Korean J Radiol; 2022 Mar; 23(3):322-332. PubMed ID: 35029083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
    Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
    Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: inter-observer agreement study.
    Kim HY; Lee YJ; Chang W; Cho J; Park JH; Lee JC; Kim J; Hwang JH; Kim YH
    Eur Radiol; 2022 Jun; 32(6):3799-3807. PubMed ID: 35032213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior Superior Mesenteric Artery (SMA) First Approach vs. Standard Pancreaticoduodenectomy in Patients with Resectable Periampullary Cancers: a Prospective Comparison Focusing on Circumferential Resection Margins.
    Pal S; George J; Singh AN; Mathur S; Dash NR; Garg P; Sahni P; Chattopadhyay TK
    J Gastrointest Cancer; 2018 Sep; 49(3):252-259. PubMed ID: 28315190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Dark-Blood Dual-Energy CT Images for Predicting Vascular Involvement and R0 Resection in Patients With Pancreatic Cancer.
    Si K; Wu H; Yang M; Guo Y; Zhang X; Ding C; Xue J; Han P; Li X
    AJR Am J Roentgenol; 2023 Jun; 220(6):838-848. PubMed ID: 36541594
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
    Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
    Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of survival length after pancreaticoduodenectomy for pancreatic head adenocarcinoma depending on tumor characteristics detected by means of computed tomography and resection margins status.
    Prochazka V; Hlavsa J; Kunovsky L; Farkasova M; Potrusil M; Andrasina T; Litavcova A; Mazanec J; Dolina J; Ostrizkova L; Eid M; Kovalcikova P; Pavlik T; Kala Z
    Neoplasma; 2020 Nov; 67(6):1319-1328. PubMed ID: 32614234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer.
    Bian Y; Jiang H; Ma C; Cao K; Fang X; Li J; Wang L; Zheng J; Lu J
    Abdom Radiol (NY); 2020 Mar; 45(3):759-773. PubMed ID: 31932878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-Dimensional Fixation: Pathological Protocol Following Pancreaticoduodenectomy with Portal Vein Resection for Pancreatic Cancer.
    Tanaka M; Inoue Y; Matsueda K; Hiratsuka M; Muto M; Kawakatsu S; Ono Y; Mise Y; Ishizawa T; Ito H; Takahashi Y; Takazawa Y; Saiura A
    J Gastrointest Surg; 2020 Mar; 24(3):619-626. PubMed ID: 30937709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
    Tran Cao HS; Balachandran A; Wang H; Nogueras-González GM; Bailey CE; Lee JE; Pisters PW; Evans DB; Varadhachary G; Crane CH; Aloia TA; Vauthey JN; Fleming JB; Katz MH
    J Gastrointest Surg; 2014 Feb; 18(2):269-78; discussion 278. PubMed ID: 24129826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
    Jang JK; Byun JH; Kang JH; Son JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Kim SC; Lee MG
    Eur Radiol; 2021 Feb; 31(2):813-823. PubMed ID: 32845389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of preoperative tumour contact with superior mesenteric-portal vein in patients with resectable pancreatic head cancer.
    Ausania F; Sanchez-Cabus S; Senra Del Rio P; Borin A; Ayuso JR; Bodenlle P; Espinoza S; Cuatrecasas M; Conill C; Saurí T; Ferrer J; Fuster J; García-Valdecasas JC; Melendez R; Fondevila C
    Langenbecks Arch Surg; 2021 Aug; 406(5):1443-1452. PubMed ID: 33475833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis.
    Park S; Jang JK; Byun JH; Kim JH; Lee SS; Kim HJ; Hong SB; Park SH
    Eur Radiol; 2021 May; 31(5):3383-3393. PubMed ID: 33123793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
    Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.
    Park SJ; Jang S; Han JK; Kim H; Kwon W; Jang JY; Lee KB; Kim H; Lee DH
    Eur Radiol; 2021 Sep; 31(9):6889-6897. PubMed ID: 33740095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study.
    Rigiroli F; Hoye J; Lerebours R; Lafata KJ; Li C; Meyer M; Lyu P; Ding Y; Schwartz FR; Mettu NB; Zani S; Luo S; Morgan DE; Samei E; Marin D
    Radiology; 2021 Dec; 301(3):610-622. PubMed ID: 34491129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
    Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM
    HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.
    Hong SB; Lee SS; Kim JH; Kim HJ; Byun JH; Hong SM; Song KB; Kim SC
    Radiology; 2018 Dec; 289(3):710-718. PubMed ID: 30251929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative radiographic vascular involvement score predicts the prognosis of resected pancreatic head adenocarcinoma.
    Onoe S; Kaneoka Y; Maeda A; Takayama Y; Fukami Y
    Langenbecks Arch Surg; 2017 May; 402(3):439-446. PubMed ID: 28246964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection.
    Ren W; Xourafas D; Ashley SW; Clancy TE
    Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.